[Methodological contribution to the controlled measurement of platelet aggregation]

Area of Science:

• Biomedical Science
• Pharmacology
• Hematology

Background:

• Platelet aggregation is crucial for hemostasis and thrombosis.
• Assessing platelet function is vital for evaluating antiplatelet therapies.
• Standardized methods are needed for reliable platelet aggregation studies.

Purpose of the Study:

• To establish and validate a reproducible method for measuring collagen-induced platelet aggregation.
• To assess the stability and reliability of the platelet aggregation assay over time.
• To evaluate the utility of the validated method for testing anti-inflammatory agents.

Main Methods:

• Collagen-induced platelet aggregation was measured using the Born aggregometer.
• Key parameters assessed included the maximum amount and velocity of aggregation.
• Reproducibility was tested on consecutive days and over extended periods (4 and 8 weeks).
• A controlled crossover study was conducted to test a non-steroid anti-inflammatory agent (RU 43-715).

Main Results:

• No significant differences in platelet aggregation measurements were observed on 3 consecutive days.
• Identical results were obtained in the same volunteers 4 and 8 weeks after the initial testing.
• The experimental procedure demonstrated high reliability and reproducibility.

Conclusions:

• The described experimental conditions provide a stable and reliable method for assessing platelet aggregation.
• This validated assay is suitable for controlled studies, including drug efficacy testing, over extended periods.
• The method is robust enough for evaluating agents like non-steroid anti-inflammatory drugs on platelet function.